KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Shares Outstanding (Diluted Average): 2019-2025

Historic Shares Outstanding (Diluted Average) for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to $255.6 million.

  • Hims & Hers Health's Shares Outstanding (Diluted Average) rose 8.71% to $255.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $255.6 million, marking a year-over-year increase of 8.71%. This contributed to the annual value of $236.8 million for FY2024, which is 13.12% up from last year.
  • Per Hims & Hers Health's latest filing, its Shares Outstanding (Diluted Average) stood at $255.6 million for Q3 2025, which was down 0.48% from $256.8 million recorded in Q2 2025.
  • Hims & Hers Health's Shares Outstanding (Diluted Average)'s 5-year high stood at $256.8 million during Q2 2025, with a 5-year trough of $153.1 million in Q1 2021.
  • For the 3-year period, Hims & Hers Health's Shares Outstanding (Diluted Average) averaged around $230.0 million, with its median value being $234.8 million (2024).
  • Data for Hims & Hers Health's Shares Outstanding (Diluted Average) shows a peak YoY soared of 461.68% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Hims & Hers Health's Shares Outstanding (Diluted Average) stood at $186.8 million in 2021, then increased by 9.49% to $204.5 million in 2022, then climbed by 2.36% to $209.3 million in 2023, then climbed by 13.12% to $236.8 million in 2024, then increased by 8.71% to $255.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $255.6 million in Q3 2025, compared to $256.8 million in Q2 2025 and $246.6 million in Q1 2025.